FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069587411> ?p ?o ?g. }

• W2069587411 endingPage "136" @default.
• W2069587411 startingPage "123" @default.
• W2069587411 abstract "Introduction: Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system leading to progressive neurodegeneration and disability. Until 2010, all approved disease-modifying drugs for MS required parenteral administration, which is associated with suboptimal adherence. It was anticipated that new approaches to treatment, including oral agents such as cladribine tablets, may improve adherence. In 2011, the development of cladribine tablets was stopped following negative feedback from the EMA and FDA. Areas covered: This article provides an overview of the chemistry, mechanism of action and pharmacological properties of cladribine tablets therapy, and highlights the rationale for its development as an oral treatment for MS. Key efficacy and safety data from the pivotal Phase III CLARITY study are presented, providing context for the opinion received from the regulatory agencies. Expert opinion: Despite the promising efficacy data observed in the cladribine tablets clinical trial program, regulatory agencies identified a potential risk of increased malignancies, and raised concerns about the implications of sustained lymphocyte depletion. Following the feedback received from the regulatory agencies, Merck Serono made the decision to withdraw the agent from the regulatory approval process. The experience gained will benefit other research efforts to address the outstanding unmet treatment needs of patients with relapsing MS." @default.
• W2069587411 created "2016-06-24" @default.
• W2069587411 creator A5011944665 @default.
• W2069587411 creator A5020755288 @default.
• W2069587411 creator A5040723911 @default.
• W2069587411 creator A5043178404 @default.
• W2069587411 creator A5074759103 @default.
• W2069587411 date "2012-12-21" @default.
• W2069587411 modified "2023-09-27" @default.
• W2069587411 title "Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis" @default.
• W2069587411 cites W121485390 @default.
• W2069587411 cites W1566384842 @default.
• W2069587411 cites W1966560563 @default.
• W2069587411 cites W1967838438 @default.
• W2069587411 cites W1974697153 @default.
• W2069587411 cites W1978971614 @default.
• W2069587411 cites W1981220317 @default.
• W2069587411 cites W1983559242 @default.
• W2069587411 cites W1985129563 @default.
• W2069587411 cites W1995570857 @default.
• W2069587411 cites W1996266000 @default.
• W2069587411 cites W1996325159 @default.
• W2069587411 cites W2000855058 @default.
• W2069587411 cites W2004076487 @default.
• W2069587411 cites W2008060191 @default.
• W2069587411 cites W2013874235 @default.
• W2069587411 cites W2015734871 @default.
• W2069587411 cites W2016149155 @default.
• W2069587411 cites W2019582599 @default.
• W2069587411 cites W2020509480 @default.
• W2069587411 cites W2021623849 @default.
• W2069587411 cites W2033175786 @default.
• W2069587411 cites W2036769788 @default.
• W2069587411 cites W2042580058 @default.
• W2069587411 cites W2043591841 @default.
• W2069587411 cites W2044022462 @default.
• W2069587411 cites W2047098009 @default.
• W2069587411 cites W2070513259 @default.
• W2069587411 cites W2070625707 @default.
• W2069587411 cites W2077355355 @default.
• W2069587411 cites W2081499586 @default.
• W2069587411 cites W2082470201 @default.
• W2069587411 cites W2085686132 @default.
• W2069587411 cites W2092831759 @default.
• W2069587411 cites W2099167011 @default.
• W2069587411 cites W2103294049 @default.
• W2069587411 cites W2103758700 @default.
• W2069587411 cites W2105053272 @default.
• W2069587411 cites W2106466834 @default.
• W2069587411 cites W2107422246 @default.
• W2069587411 cites W2107424415 @default.
• W2069587411 cites W2118285512 @default.
• W2069587411 cites W2122397885 @default.
• W2069587411 cites W2139204856 @default.
• W2069587411 cites W2139367012 @default.
• W2069587411 cites W2141141209 @default.
• W2069587411 cites W2141919552 @default.
• W2069587411 cites W2162696342 @default.
• W2069587411 cites W2163089957 @default.
• W2069587411 cites W2166983650 @default.
• W2069587411 cites W2166992004 @default.
• W2069587411 cites W2169098250 @default.
• W2069587411 cites W218420279 @default.
• W2069587411 cites W4211254511 @default.
• W2069587411 cites W4239852294 @default.
• W2069587411 cites W4256594459 @default.
• W2069587411 cites W78071506 @default.
• W2069587411 doi "https://doi.org/10.1517/14656566.2013.754012" @default.
• W2069587411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23256518" @default.
• W2069587411 hasPublicationYear "2012" @default.
• W2069587411 type Work @default.
• W2069587411 sameAs 2069587411 @default.
• W2069587411 citedByCount "24" @default.
• W2069587411 countsByYear W20695874112012 @default.
• W2069587411 countsByYear W20695874112014 @default.
• W2069587411 countsByYear W20695874112015 @default.
• W2069587411 countsByYear W20695874112017 @default.
• W2069587411 countsByYear W20695874112018 @default.
• W2069587411 countsByYear W20695874112019 @default.
• W2069587411 countsByYear W20695874112020 @default.
• W2069587411 countsByYear W20695874112021 @default.
• W2069587411 countsByYear W20695874112022 @default.
• W2069587411 crossrefType "journal-article" @default.
• W2069587411 hasAuthorship W2069587411A5011944665 @default.
• W2069587411 hasAuthorship W2069587411A5020755288 @default.
• W2069587411 hasAuthorship W2069587411A5040723911 @default.
• W2069587411 hasAuthorship W2069587411A5043178404 @default.
• W2069587411 hasAuthorship W2069587411A5074759103 @default.
• W2069587411 hasConcept C126322002 @default.
• W2069587411 hasConcept C151730666 @default.
• W2069587411 hasConcept C177713679 @default.
• W2069587411 hasConcept C203014093 @default.
• W2069587411 hasConcept C2776036978 @default.
• W2069587411 hasConcept C2777703276 @default.
• W2069587411 hasConcept C2779200787 @default.
• W2069587411 hasConcept C2779343474 @default.
• W2069587411 hasConcept C2780640218 @default.
• W2069587411 hasConcept C3020580240 @default.

• next